SCHEMBL28866520

SCHEMBL28866520

N#CCc1ccc(N2CC=CCC2)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
PAK1 Q13153 1/20 0.37
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
MAOA P21397 3/20 0.35
AXL P30530 1/20 0.35
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
GFER P55789 1/20 0.32
ENPP2 Q13822 1/20 0.32
MMP3 P08254 1/20 0.31
DRD2 P14416 1/20 0.30
DRD3 P35462 1/20 0.30
KDM4E B2RXH2 2/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7906697 0.80 ALDH1A1 (0.50) MAPTPAK1ADRA1DADRA1AADRA1B
SCHEMBL8437508 0.77 ALDH1A1 (0.49) MAPTADRA1DADRA1AADRA1BALDH1A1
SCHEMBL13369342 0.77 MAPT (0.44) MAPTPAK1ADRA1DADRA1AADRA1B
SCHEMBL5739853 0.73 ALDH1A1 (0.58) MAPTALDH1A1SMN1; SMN2TDP1LMNA
SCHEMBL4565387 0.70 SMN1; SMN2 (0.46) MAPTALDH1A1SMN1; SMN2TDP1LMNA
SCHEMBL6676186 0.69 ESR1 (0.47) ADRA1DADRA1AADRA1B
SCHEMBL8436491 0.68 GPR119 (0.49) MAPTALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL10237127 0.68 ALDH1A1 (0.41) MAPTALDH1A1SMN1; SMN2TDP1LMNA
SCHEMBL3124970 0.68 AR (0.40) ALDH1A1LMNAKDM4E
SCHEMBL5748476 0.68 ALDH1A1 (0.62) MAPTMAOAALDH1A1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071560-A Thienopyridine formamide as ubiquitin-specific protease inhibitor 福马治疗股份有限公司 2018-12-21 CN disclosed